180 filings
Page 7 of 9
8-K
45xa4 4nm
20 Dec 17
Regulation FD Disclosure
12:00am
8-K
nkl7b9aun jufkhqe40i
21 Nov 17
Pieris Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
12:00am
8-K
asov2f mu93f8hj46
14 Nov 17
Regulation FD Disclosure
12:00am
8-K
4fhtiwg6
8 Nov 17
Results of Operations and Financial Condition
12:00am
8-K
bt42fg2urea6d6 lzi
17 Oct 17
Regulation FD Disclosure
12:00am
8-K
b5xgtgq2sp73zcbir
18 Sep 17
Regulation FD Disclosure
12:00am
8-K
q3pq72 u9abd
11 Sep 17
Regulation FD Disclosure
12:00am
8-K
hcvit3t5
10 Aug 17
Pieris Pharmaceuticals Reports Financial Results for the Second
12:00am
8-K
dym7bhtgll2xl0af
5 Jul 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8u5nt 8i2
5 Jun 17
Regulation FD Disclosure
12:00am
8-K
k5xzyy1cm2
22 May 17
Pieris Pharmaceuticals Appoints James Geraghty to its Board of Directors
12:00am
8-K
8ysi2wznw z0tiem
11 May 17
Results of Operations and Financial Condition
12:00am
8-K
lqt1 bs9lbu7l6e
3 May 17
Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases
12:00am
8-K
s97 85d111wbnngn1r5c
4 Apr 17
Regulation FD Disclosure
12:00am
8-K
jjak4
23 Mar 17
Pieris Pharmaceuticals Reports Full-year 2016
12:00am
8-K
jmr9cbsx71jmc
22 Mar 17
27th Annual Oppenheimer Healthcare Conference
12:00am
8-K
og0uxwkws l91n6
27 Feb 17
Pieris Signs 1st Partnership for Anemia DrugPRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical
12:00am
8-K
scjwyhg2muxh1jgy st
7 Feb 17
Pieris Announces Management Transition
12:00am
8-K
egr 6cfhi1z8
9 Jan 17
Regulation FD Disclosure
12:00am
8-K
txuxh33dnqqsa8v
5 Jan 17
Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncologyCo-development Alliance
12:00am